GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bakhu Holdings Corp (OTCPK:BKUH) » Definitions » Debt-to-Equity

Bakhu Holdings (Bakhu Holdings) Debt-to-Equity

: -0.82 (As of Jan. 2024)
View and export this data going back to 2009. Start your Free Trial

Bakhu Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.41 Mil. Bakhu Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $7.63 Mil. Bakhu Holdings's Total Stockholders Equity for the quarter that ended in Jan. 2024 was $-9.78 Mil. Bakhu Holdings's debt to equity for the quarter that ended in Jan. 2024 was -0.82.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Bakhu Holdings's Debt-to-Equity or its related term are showing as below:

BKUH' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.15   Med: -0.89   Max: -0.2
Current: -0.82

During the past 10 years, the highest Debt-to-Equity Ratio of Bakhu Holdings was -0.20. The lowest was -1.15. And the median was -0.89.

BKUH's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs BKUH: -0.82

Bakhu Holdings Debt-to-Equity Historical Data

The historical data trend for Bakhu Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bakhu Holdings Annual Data
Trend Jul08 Jul09 Jul10 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Debt-to-Equity
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.98 -0.89 -0.78 -0.89 -0.72

Bakhu Holdings Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.79 -0.76 -0.72 -0.74 -0.82
Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bakhu Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bakhu Holdings Debt-to-Equity Distribution

For the Drug Manufacturers industry and Healthcare sector, Bakhu Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Bakhu Holdings's Debt-to-Equity falls into.


Bakhu Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Bakhu Holdings's Debt to Equity Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(6.745 + 0) / -9.326
=-0.72

Bakhu Holdings's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.41 + 7.634) / -9.78
=-0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bakhu Holdings  (OTCPK:BKUH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Bakhu Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Bakhu Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bakhu Holdings (Bakhu Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bakhu Holdings Corp (OTCPK:BKUH) » Definitions » Debt-to-Equity
Comparable Companies
ORGO PROC SIGA LFCR RGC ASRT CHHE EGRX ALIM EOLS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
One World Trade Center, Suite 130, Long Beach, CA, USA, 90831
Website
https://www.bakhuholdings.com
Bakhu Holdings Corp is a development stage company engaged in the production, manufacturing, and sale of cannabis and byproducts. The company also provides cannabis-related research, teaching and education for both medical and other purposes, and all medical uses and applications of cannabis, within the Territory.
Executives
Tom Vaknin director SPYROU KYPRIANOU 16, PYGROS / LIMMASOL G4 4529
Moshe Morgenstern director MENACHEM BEGIN 88, PETAH TIKVAH/CENTRAL DISTRICT L3 49504
Geoffrey Robert Dixon 10 percent owner 16 SHOBY LANE, GRIMSTON X0 LE14 3DD
Michael Richard Hawthorne officer: Deputy CEO 20 LARKSBOROUGH AVENUE, COUNTY DOWN X0 BT23 8SU
Garcia La Sienra Garcia Juan Carlos director, officer: CFO 3 SHANEWOOD CT, THE WOODLANDS TX 77382
Sagi Rami Rozen director HOUSE NUMBER 8, 8 AGIAS TRIADAS STREET (MOUTTAGIAKA), LIMASSOL G4 4527
Cell Science Holding, Ltd. 10 percent owner PANTELI KATELARI 18A, AGIOS IOANNIS, LIMASSOL G4 3012
Mentone, Ltd. 10 percent owner 3 COPLOW CRESCENT, SYSTON, LEICESTER X0 LE7 2JE
Inter-m Traders Fz, Lle 10 percent owner 18A PENTELI KATELARI, LIMASSOL G4 3021
Thomas K Emmitt director, officer: President, CEO and Secretary ONE WORLD TRADE CENTER, SUITE 130, LONG BEACH CA 90831
Aristotle Popolizio director 206 PASSAIC AVENUE, ROSELAND NJ 07068
Evripides Drakos director 139C GLOUCESTER TERRACE, LANCASTER GATE, LONDON X0 W2 6DX
Peter Whitton director 3 COPLOW CRESCENT, SYSTON LEICESTER X0 LE7 2JE
Oz Corp 10 percent owner 24328 VERMONT AVENUE, SUITE 300, HARBOR CITY CA 90710